Search Blog
Categories
June 2017
M T W T F S S
« May    
 1234
567891011
12131415161718
19202122232425
2627282930  

Tags

NTRP SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Neurotrope, Inc. and Lead Plaintiff Deadline of July 17, 2017

By Levi & Korsinsky, LLP

NEW YORK, NY / ACCESSWIRE / June 22, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired shares of Neurotrope, Inc. (“Neurotrope”) (NASDAQ: NTRP) between January 7, 2016, and April 28, 2017. You are hereby notified that Levi & Korsinsky has commenced the action Hinshaw v. Neurotrope, Inc., et al. (Case No. 1:17-cv-03718) in the USDC for the Southern District of New York. To get more information go to: http://www.zlk.com/pslra/neurotrope-inc?wire=1, or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that, throughout the class period, Neurotrope issued materially false and misleading statements and/or failed to disclose material information concerning the efficacy of its lead product candidate, Bryostatin-1. On May 1, 2017, Neurotrope issued a press release announcing “positive top-line results” of the pivotal Phase 2b trials of Bryostatin-1, noting “improvement in patients with moderate to severe Alzheimer’s disease.” However, the underlying trial data contradicts these representations, as the top-line data relating to the 20 microgram dose of Bryostatin-1 failed to produce results that were statistically significant. In addition, Neurotrope failed to disclose statements regarding the efficacy of the 40 microgram dose with regard to its primary and secondary endpoints. Upon this news, shares of Neurotrope fell from a close of $18.81 on April 28, 2017, to a close of $6.97 per share on May 1, 2017.

Take Action: if you suffered a loss in Neurotrope, you have until July 17, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY10004
Tel: (212) 363-7500
Toll-Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 466545

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of JBS S.A. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 21, 2017 – JBSAY

By Levi & Korsinsky, LLP

NEW YORK, NY / ACCESSWIRE / June 22, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of JBS S.A. (“JBS”) (OTCQX: JBSAY) between June 2, 2015 and May 19, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Eastern District of New York. To get more information, go to: http://www.zlk.com/pslra-sb/jbs?wire=1, or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that, throughout the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) JBS executives bribed regulators and politicians to subvert food inspections of its plants and overlook unsanitary practices, such as processing rotten meat and running plants with traces of salmonella; (2) JBS Chairman, Joesley Batista, was providing monthly bribery payments to a former Brazilian government official and a lobbyist; (3) there were irregularities with the loans JBS received from Brazilian state-owned development bank BNDES; (4) JBS and other entities controlled by JBS Chairman, Joesley Batista, and JBS CEO, Wesley Batista, made suspicious trades that exhibit signs of possible insider trading prior to the revelation of a plea deal by JBS’ top executives; and (5) consequently, defendants’ statements about JBS’ business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

If you suffered a loss in JBS, you have until July 21, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll-Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 466546

IIROC Trade Halt – West African Resources Limited

Vancouver, British Columbia–(Newsfile Corp. – June 22, 2017) – The following issues have been halted by IIROC:

Company:

West African Resources Limited

TSX-V Symbol:

WAF

Reason:

At the Request of the Company Pending News

Halt Time (ET)

09:41

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

– 30 –

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

IIROC Trade Halt – VIQ Solutions Inc.

Vancouver, British Columbia–(Newsfile Corp. – June 22, 2017) – The following issues have been halted by IIROC:

Company:

VIQ Solutions Inc.

TSX-V Symbol:

VQS

Reason:

At the Request of the Company Pending News

Halt Time (ET)

10:01

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

– 30 –

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

5 Canadian Marijuana Stocks with Industry Leading Gross Margins

5 Canadian Marijuana Stocks with Industry Leading Gross Margins

Toronto, Ontario (FSCwire) – Being able to sell products at a high margin is a good sign of efficiency. Doing so leaves more cash to dedicate to other expenses and service debt obligations. Identifying companies with high gross margins in the young marijuana industry is important because operating costs are likely to decrease as the industry matures, leaving these companies with high earnings potential. Today we have identified five Canadian marijuana stocks with gross margins well above its industry peers, which includes Aphria Inc. (TSX: APH) and CanniMed Therapeutics Inc. (TSX: CMED).

Read the full article at https://smallcappower.com/investing-ideas/canadian-marijuana-stocks-gross-margins/

Related: For Our Complete Coverage Of Canadian Marijuana Stocks Click Here

About SmallCapPower.com

SmallCapPower.com (SCP) is the industry’s most trusted resource for small cap stocks, offering unprecedented access to the research and tools you need to help uncover the next big thing.

Disclosure

Except for the historical information presented herein, matters discussed in this document contain forward- looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Ubika Research and www.smallcappower.com (are both divisions of Ubika Corporation), and are not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this report. For making specific investment decisions, readers should seek their own advice.

Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.

For full disclosure please visit: http://www.smallcappower.com/pages/small-cap-power-disclosure.

For additional information contact:

Mark Thorburn- Manager, Media Relations Email: mark@smallcappower.com

Phone: 416.646.1941

To view this press release as a PDF file, click onto the following link:

Maximum News Dissemination by FSCwire. http://www.fscwire.com

Copyright © 2017 Filing Services Canada Inc.

Practical Research Partners Initiates Coverage for UMF Group Inc. with ‘Undervalued’ View UMF Group “Well-Positioned” in Growing Cannabinoid Market

By Emerging Markets Report

ORLANDO, FL / ACCESSWIRE / June 22, 2017 / Practical Research Partners is pleased to announce that it has initiated coverage of UMF Group Inc. (OTC PINK: UMFG). The full report is available free of charge at the following link:

http://www.practicalresearchpartners.com/Files/bc3cc7dc-843b-409c-ba3a-53467d5fba61/UMF%20Group%20Inc.pdf

Practical Research Partner’s current and qualified view of UMF Group is ‘Undervalued:’

From the report:

We initiate coverage on UMF Group Inc. (OTC PINK: UMFG) with a view of ‘Undervalued.’ UMFG is an innovative medical marijuana company which aims to develop cannabinoid based drugs using a proprietary ‘whole plant extraction’ method. UMFG’s cannabinoid applications (prodrugs) can be administered to enable selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract. Site-specific delivery could enable oral drug formulations of cannabinoids to provide therapeutic benefits while reducing or avoiding the systemic delivery of psychoactive THC into the bloodstream.

UMFG currently generates negligible revenues (~$12,098 in 1Q17 and $10,237 in FY16), but the prospects look bright considering the rapid expansion of the medical marijuana market. We believe the superior efficacy of the company’s proprietary platform, faster regulatory approvals and burgeoning cannabinoid based pharmaceuticals market augur well for UMFG. The increasing interest among researchers and healthcare providers regarding the therapeutic uses of marijuana is likely to fuel further growth. With more states easing marijuana restrictions, UMFG represents a unique investment opportunity; however, we caution that the risk remains high.

Other excerpts:

Targeted delivery ensures greater efficacy: A prodrug is a medication or compound that, after administration, is metabolized (i.e., converted within the body) into a pharmacologically active drug. Prodrugs are typically designed to overcome well-known drawbacks of currently available therapies. UMFG’s prodrug technology enables the selective targeting of specific tissues or organs, including the gut or brain, enabling the drug to have a more targeted effect. As of 2015, there were approximately 15 prodrugs that had been classified as blockbusters, defined as having annual sales in excess of $1 billion.

Low risk regulatory strategy to lead to faster approvals: UMFG plans to take advantage of a more efficient FDA review and approval process that is available for ‘whole plant extracts’, which reduces the need for large and expensive clinical trials. UMFG plans to develop whole plant pharmaceutical products for symptomatic relief of pain, cramping, and muscle spasticity. There is extensive clinical evidence supporting the potential efficacy of cannabinoids for treatment of each of these indications, including thorough clinical trials conducted by independent investigators. Because there already exists independent verification of the active drug’s safety and efficacy, such products may receive marketing approval more quickly than others.

Large Addressable market: The global medical marijuana market is expected to reach a value of $55.8 billion by 2025, according to a new report by Grand View Research. Washington D.C. along with 28 states have legalized marijuana for medical uses. More states are moving towards granting approval for using marijuana in therapeutic applications which is one of the crucial factors driving the demand. UMFG, with its unique cannabinoid applications, is well positioned to take advantage of the industry tailwind.

More excerpts including risks and competition are available in the full report.

To receive more reports via email please register at www.PracticalResearchPartners.com

About Practical Research Partners:

“Hype-Free, Leverageable Information for Active Investors”

Practical Research Partners (PRP) combines efficient, insightful research with the widest distribution to active investors available. PRP endeavors to
examine a Company’s core industry through a broader sector view and then drills down to comment on the Company’s prospects within. Each Research Report, completed by highly qualified analysts with appropriate credentials and small and microcap strata understanding will detail leading success components or lack thereof for the subject equity. Practical Research Partners is the analytical arm of Emerging Markets Consulting.

Disclaimer:

Practical Research Partners (“PRP”), its principals, affiliates, representatives, subcontractors or agents (hereafter referred to as “PRP” or “we” or “us”) prepare and/or assist others in preparing and publishing oral and written information on selected companies (the “Profiled Company” ) and their securities (the “Securities”) in various contexts, including but not limited to corporate and business profiles, alerts, summaries, reports, and press releases (hereafter referred to as the “Information”) through various methods, including but not limited to: (a) double opt-in spam compliant emails; (c) mail and courier; (d) PRP’s website’s at profiling the Profiled Company and otherwise through the worldwide web. In certain cases, we are merely a distributor of such publications, i.e. a Profiled Company’s press release, in which case, as in all other situations, PRP conducts no review of said publications received from any party such as an investor relations firm that directly contracts with a Profiled Company or a third party shareholder. We do not conduct any due diligence whatsoever for any of our publications, whether we act only as a distributor pursuant to an agreement with another publisher or investor relations firm or directly contract with the Profiled Company or third party shareholder; rather, we rely upon the information of the Profiled Company we receive from the Profiled Company or other investor relations firm or third party shareholder, which similarly may not conduct any due diligence upon the Information of the stocks of the Profiled Company qualify as “penny stocks” under the Securities and Exchange Commission’s (“SEC”) penny stock rules and regulations because, among other things, they have a price of less than $5.00 per share. Penny stocks are subject to material risks that you should be acutely aware of, as detailed in the bulleted risk factor section presented below. Please read the full disclaimer here: http://www.practicalresearchpartners.com/Disclaimer.aspx

For more informative reports such as this, please sign up at http://www.emergingmarketsllc.com/newsletter.php

Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer,
must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the
consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.

We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before,
during or after our dissemination of the Information, and make profits therefrom.

EMC has been paid 65,000 by Dedicated Emails on behalf of UMF Group Inc. for various marketing services including this
report. EMC does not independently verify any of the content linked-to from this editorial.

http://emergingmarketsllc.com/disclaimer.php

Emerging Markets Consulting, LLC

Florida Office
15701 State Road 50, Suite #205
Clermont, FL 34711
E-mail: jamespainter@emergingmarketsllc.com
Web: www.emergingmarketsllc.com

SOURCE: Emerging Markets Consulting, LLC

ReleaseID: 466523

JGR Capital Partners Initiates Coverage on Arkados Group, Inc.

By JGR Capital Partners

NEW YORK, NY / ACCESSWIRE / June 22, 2017 / JGR Capital Partners, a leading equity research firm, has announced it has initiated coverage on Arkados Group, Inc. (OTC PINK: AKDS) with a base case financial valuation of $1.13 per share.

The full report can be found here: AKDS Initiation.

Arkados Group, Inc., through its subsidiaries, is a global provider of scalable and interoperable Industrial Internet of Things (IoT) solutions that help customers increase efficiency and reduce cost. The company offers cutting-edge solutions, focused on industrial automation and energy management, comprised of our software and hardware platforms that enable advanced machine to machine communication.

Key Report Highlights:

Strategic business synergies provide comprehensive energy management. According to the US Environmental Protection Agency estimates, American businesses can reduce on average 30% of their energy use by correcting physical inefficiencies in the areas of lighting, boiler and combined heat and power systems, and industrial machinery. AES benefits the businesses overseeing physical retrofitting of buildings to upgrade the energy assets, implementing the most energy- and cost-efficient solutions in lighting, heating, power, and other industrial machinery. Simultaneously, Arkados software helps to further improve efficiencies through innovative energy management, controlling, and monitoring of these assets. Arkados software technology enables smart monitoring of devices, energy management, and intelligent control through cloud services (IoT), which is ideal for Smart Manufacturing, Smart Building, and Smart Machine operations.

Green building initiatives bode well for Arkados. According to a Forbes study, commercial building owners and managers will invest an estimated $960bn globally between now and 2023 on green building in areas including energy-efficient heating, ventilation and air conditioning, windows, lighting, plumbing fixtures, and other key technologies. Arkados is well positioned to benefit from huge market demand for energy efficient and environmental friendly buildings, given its unique business synergies being a software developer as well as system integrator.

KaloBios has taken numerous positive steps to turn around the company including: extinguishing Martin Shkreli’s stake and all association with the company, becoming current with their SEC filings and the new management team successfully executing on the pipeline so far.

The company is a viable acquisition target. With its well-crafted business divisions and strategic positioning within the growing energy conservation and IoT industries, Arkados also emerges as a lucrative acquisition target. On one hand, it offers energy conservation technology as well as a deeper collaboration through IoT software for energy services companies; on the other hand, it offers its energy connections to monetize IoT software business for IoT solution companies. Moreover, Arkados can prove to be a value addition for the service divisions of companies involved in designing, manufacturing and selling of energy and related equipment. The acquisition market is hot for such businesses; GE-backed Current acquired networked building firm Daintree Networks for $77mn last year. For any large company, Arkados is an attractive buy being a small company that provides significant value in its unique business strategy, strong IP, growing client base, and strategic partnerships, in addition to having an experienced management team.

SolBright acquisition brings synergies and open up further synergistic opportunities. In May 2017, the Company completed its acquisition of SolBright Renewable Energy, LLC, a leading designer and developer of Solar Energy systems for $15mn. This transaction bodes well for Arkados’ growth story, allowing it to expand its AES business, which has similar offerings, into the rapidly growing renewables energy industry. SolBright’s $40mn in distributed generation EPC projects backlog and growing pipeline will not only add to Arkados’ future revenues, but also open up customer expansion opportunities for its IoT solutions.

JGR Capital Partners LLC is being compensated by the Arkados for producing research materials regarding Arkados and its securities. Payment is made in cash and is billed annually. As of 06/16/2017 the issuer had paid us $10,000 for its services, which commenced June 2017. Additional fees may have accrued since then. Disclosures pertaining to this report can be found at www.jgrcapitalpartners.com.

About Arkados Group, Inc.:

Arkados’ core strengths lie in our world-class expertise in software design and system integration, our experienced management team, our strong intellectual property portfolio, our flexible, scalable approach, our multi-national partnerships, our direct access to top-tier customers, as well as valuable channel and OEM partners, and unwavering commitment to collaboration and to doing more with less.More information on Arkados Group can be found at arkadosgroup.com.

About JGR Capital Partners:

JGR Capital Partners is an international equity research and digital investor relations firm that focuses on companies under $2 billion in market capitalization. The firm is headquartered in New York City, with affiliate offices in Los Angeles, Sao Paulo, and Shanghai. Our team of experienced analysts form investment theses based on company and sector expertise, with a strict focus on fundamentals and valuation. For more information on JGR Capital Partner’s, visit our website at www.jgrcapitalpartners.com.

SOURCE: JGR Capital Partners

ReleaseID: 466411

Ubiquity Inc.’s Largest Shareholders Ask Chris Carmichael to Step Back in as Interim CEO

By Ubiquity, Inc.

IRVINE, CA / ACCESSWIRE / June 22, 2017 / Ubiquity, Inc. (OTC PINK: UBIQ) (“Ubiquity” or the “Company”), is a vertically integrated, technology-focused media company. Ubiquity’s portfolio of patents and intellectual property cover virtual, augmented, mixed and immersive reality as well as the Internet-of-Things, announced today that a group of the largest shareholders have come together to ask Chris Carmichael to step back in as interim CEO.

The largest shareholders of Ubiquity Inc. have asked Chairman Chris Carmichael to assume the role of Interim CEO. The move comes from an outcry from a number of Ubiquity shareholders representing a majority of the Ubiquity shares and the shareholders appear to be steadfastly behind Carmichael’s return.

Chairman Chris Carmichael said Wednesday he has agreed to step back into the role of chief executive, as the interim CEO, as part of a plan to restructure the company, resolve the outstanding note holder debt, fortify its management organization and restore timely financial reporting.

Carmichael, a founder who was instrumental in building this business from the ground up and a visionary behind the company’s patent portfolio said, “Looking ahead, the reality we face is both demanding and exciting. It’s demanding because there are no overnight fixes and we have to make a series of challenging decisions, and exciting as we look towards the future.”

Ubiquity has come under increasing pressure resulting from delinquent financial filings and the resignation of its interim CEO Nicholas Mitsakos in August of 2016. Ubiquity has struggled over the last 12 months after learning from outsiders of the indictment of Mr. Mitsakos in matters not relating to Ubiquity, its officers or directors in August of 2016. Although Mr. Mitsakos’ legal troubles have nothing to do with Ubiquity, many attempts have been made to discredit Ubiquity and its management by these events. Ubiquity is confident that the company can move past this traumatic event and prosper under the guidance and focus of the management team.

“I am confident with Chris Carmichael back in as interim CEO he will be able to deliver. He knows the company and its products better than anyone. I believe since he is the inventor of Ubiquity’s patents and products, and as an investor in the company there is not anyone more suitable then him,” stated Rorick Frueh, one of Ubiquity’s largest shareholders.

“As an early investor, I have watched Chris lead the company over the years and I am confident in his ability to do so in the future. I believe Chris’s leadership and vision will lead Ubiquity’s growth into the future,” stated Chuck Hinn, one of Ubiquity’s largest shareholders. “It’s important for me to have Chris continue to be in a leadership role of Ubiquity as both have been an investor since the beginning and continue to support Chris Carmichael.”

“I believe Chris has the ability as the CEO to get the company back on track and to create revenue with its patents and license agreements,” stated Jay McNamara.

“I’ve voted to place Chris Carmichael as Interim CEO. I believe there is no one other than him who could guide UBIQ’s shareholders out of our current situation. I say as he is directly aligned with us shareholders, being one of the largest shareholders he will equally reap the reward of a successful turn around or he will lose significantly if we fail, but for him will be the years of service and accrued salary on top of his shares. This is the situation every shareholder would like to have, true executive to shareholder alignment,” said shareholder James Wrbanek.

While the Ubiquity management is working towards transformation and out-of-the-box thinking, the shareholders seek to bring back to the helm Carmichael, who has a detailed understanding of Ubiquity. It makes sense in light of the challenge that Ubiquity Faces, to bring back the person that likely knows the company better than anyone – its founder and former chief executive.

About Ubiquity

Based in Irvine, California, Ubiquity is a vertically integrated, technology-focused media company. Ubiquity’s portfolio of patents and intellectual property covering virtual, augmented, mixed and immersive reality as well as the Internet-of-Things.

To find out more, visit our website at www.ubiquitycorp.com.

Forward-Looking Statements

Statements in this press release that are not descriptions of historical facts are forward-looking statements that are based on management’s current expectations and assumptions and are subject to risks and uncertainties. In some cases, you can identify forward-looking statements by terminology including “anticipates,” “believes,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “should,” “will,” “would” or the negative of these terms or other comparable terminology. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those currently anticipated, including, without limitation, the fact that: we are delinquent in filing our Form 10-K Annual Reports with the SEC and our required quarterly reports since September 30, 2015; our potential inability to raise additional funding as required to execute our business plan; the potential that our common stock may be permanently delisted from trading as a reporting company under the Exchange Act; the possibility that our creditors may sue on defaulted notes in excess of $3.0 million which could cause us to seek relief under the federal bankruptcy law; and the possibility that our common stock may never trade on any recognized securities exchange. These forward-looking statements are made as of the date of this press release, and the company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law.

Contact:

(949) 489-7600

SOURCE: Ubiquity Inc.

ReleaseID: 466520

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Snap Inc. (SNAP) & Lead Plaintiff Deadline: July 17, 2017

By Bronstein, Gewirtz and Grossman, LLC

NEW YORK, NY / ACCESSWIRE / June 22, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Snap Inc. (“Snap” or the “Company”) (NYSE: SNAP) and certain of its officers, on behalf of shareholders who purchased Snap securities (1) pursuant and/or traceable to Snap’s Registration Statement and Prospectus, issued in connection with the Company’s initial public offering on or about March 2, 2017 (the “IPO” or the “Offering”); and/or (2) on the open market between March 2, 2017 and May 15, 2017, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/snap.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

On or around March 3, 2017, Snap completed its IPO, issuing 200,000,000 shares and raising net proceeds of approximately $3.91 billion.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding its business, operational, and compliance policies. Specifically, Defendants allegedly made false and/or misleading statements and/or failed to disclose that: (1) Snap’s reported user growth was materially false and misleading; and (2) consequently, Snap’s public statements were materially false and misleading at all relevant times.

On May 10, 2017, after-market hours, Snap revealed its first quarterly report as a public company, divulging disappointing user growth at its Snapchat messaging platform. For the quarter, Snap reported 166 million daily users, only 8 million more than in the previous period and only 44 million more than the same period in the prior year – Snapchat’s slowest year-to-year growth rate in at least two years. Following this news, Snap stock dropped $4.93 per share, or 21.45%, to close at $18.05 on May 11, 2017.

On May 16, 2017, Bloomberg announced that a former Snap employee, Anthony Pompliano, had filed a lawsuit against Snap, “claim[ing] he was fired after three weeks on the job for raising questions about allegedly false growth metrics [and] seeking whistleblower protection against retaliation by [the] company.” Following this news, Snap stock dropped $0.02 per share, or 0.1%, to close at $20.72 on May 16, 2017.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/snap, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Snap, you have until July 17, 2017 to request that the Court appoint you as Lead Plaintiff. Your ability to share in any recovery doesn’t require that you serve as a Lead Plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 463431

Newly Merged Hannover House – Crimson Forest Launch Aggressive Production and Theatrical Slate to Drive 2017-2018 Revenues

By Hannover House, Inc.

LOS ANGELES, CA / ACCESSWIRE / June 22, 2017 / The recent merger of operations for Hannover House, Inc. (OTC PINK: HHSE) with Crimson Forest Entertainment Group, Inc. (OTC PINK: CRIM) has sparked a significant increase in a wide range of activities, including new title acquisitions, original feature film productions and an enhanced releasing slate, reports Chairman Jon Lim. The more aggressive posture for the combined companies is expected to have a significant impact to the company’s revenues for 2017, and set the stage for major growth in 2018.

“We are taking the steps and making the investment to build our company into a significant distributor for the North American market, and feel that we can become the preferred home for many independent producers and program suppliers,” said Lim. “As the major studios move further away from limited releases and specialty programming, we see a major void in the marketplace that is not being addressed. Well-made independent films, with strong stories, solid-casts and commercial elements are being ignored by the major studios in favor of super-hero films and bombastic tentpoles. Audiences want more, as evidenced by recent Academy and Golden Globe winning independent films. We believe that the Hannover House – Crimson Forest Entertainment Group model has the opportunity to excel in the arena of quality films under $10-million in cost,” he concluded.

On the feature production front, the company’s combined 2017 slate represents an investment of nearly $20-million dollars, led by the current action-western, “Kung Fu Cowboys” (directed by Jon Lim), along with “Delirium” (directed by Dean Jones), “The Final Minute” (directed by Rick Walker) along with three other features. Despite the company’s target to limit individual production costs to under $10-million, the total production investment for additional titles set for the company’s 2018 slate is already more than $50-million dollars, due to the number of films set to shoot.

On the distribution side, theatrical release activities will see a significant expansion with two titles this summer (“Where’s The Dragon?” and “Blood Feast”), each achieving nationwide breaks through Regal Entertainment Group. Hannover House and Crimson Forest will be announcing title specifics in the next two weeks for three more nationally-released theatrical titles set for September and October. These key theatrical titles will serve as the locomotives to drive the company’s home video, V.O.D. and Television activities during Q4 of 2017 and into early 2018, which will be supplemented with four additional theatrical titles (limited release) and eight additional direct-to-video releases.

The company’s video-on-demand streaming portal, VODWIZ, INC., will also see a significant ramp-up in activities in preparation for a major consumer launch of the site this calendar year. The VODWIZ concept was developed several years ago by Hannover House as a one-stop portal for consumers to access and stream thousands of independent movies, many of which are unavailable through other streaming platforms. The consumer launch of VODWIZ was delayed due to the time and costs required to master and configure the programming, including high-definition versions, closed captioning and delivery infrastructures. With new funding available as a result of the merger with Crimson Forest, the company can now make the capital investment to complete the mastering process and move into a consumer launch of the service. More than 20 different supplier studios have partnered with VODWIZ, collectively representing over 4,500 titles available to the site for streaming. Consumers accessing VODWIZ will have the option of streaming films on a per-transaction rental basis, or signing up for a monthly subscription service for unlimited viewing of participating titles.

Crimson Forest is working with a consortium of well-established media companies out of China, and has accessed these relationships to obtain production presales and international distribution rights. Previously announced venture partners include China Film Alliance, IQIYI, Shanghai Holdaing Culture Co. and CMC Pictures. Crimson Forest operates an international investment office out of Shanghai, China, to coordinate these activities.

Although the operational merger of Hannover House and Crimson Forest is completed, the stock-for-stock swap element of the merger is still awaiting final valuation approval and implementation. Under the swap agreement, as presently structured, public shareholders of Hannover House, Inc. will receive shares in Crimson Forest at a valuation that represents a significant premium over current stock trading levels. The combined company’s ticker-symbol will be rebranded in a nearly-simultaneous transaction. Operational management for the combined company will be Jon Lim (Chairman), Eric Parkinson (CEO), Fred Shefte (President) and Tom Sims (VP Sales, and President of VODWIZ). Three additional outside board members will also be brought into the combined company, promptly following the stock-for-stock swap. Distribution offices for HHSE-Crimson will continue to operate out of N.W. Arkansas, near the company’s primary home video retailer, Walmart Stores, Inc. Crimson will also operate a production office out of West Hollywood, California, as well as the existing offices for international finance out of Shanghai, China.

Hannover House – Crimson Forest enjoyed a robust reception at the recently completed Cannes Film Festival and Marche du Film, including the acquisition of ten new titles for North American release. The original feature production of “Shimmer,” with U.K.’s Silver Lining Productions was the company’s first announcement from the Cannes market.

Hannover House was founded in 1993 and has been operating continuously since that date in the field of book publishing. Hannover House added DVD products in 2002, and the company has since built a film library of more than 400 titles, with cumulative unit sales of over 25-million DVD discs. Crimson Forest was established five years ago, initially to accommodate the production of the Jon Lim directed feature film, “PALI ROAD.” However, the company later expanded into acquisition and distribution activities, in response to evolving market opportunities.

FOR MORE INFORMATION CONTACT:

Maryevelyn Jones
479-521-5774 / MeJones@CFF.tv

SOURCE: Hannover House, Inc.

ReleaseID: 466528